Correspondence 0001104659-23-072930 from Growth for Good Acquisition Corp (CIK 0001876714)
Growth for Good Acquisition Corp (CIK 0001876714)
Date: June 20, 2023 · CIK: 0001876714 · Accession: 0001104659-23-072930
AI Filing Summary & Sentiment
File numbers found in text: 333-271195
Referenced dates: May 26, 2023
Show Raw Text
CORRESP
1
filename1.htm
June 20, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Manufacturing
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeff
Gordon
Melissa Gilmore
Evan Ewing
Geoffrey Kruczek
Re: Growth for Good Acquisition Corp
Amendment No. 1 to Registration Statement on Form S-4
Filed May 12, 2023
File No. 333-271195
Ladies and Gentlemen:
On behalf of our client, Growth for Good Acquisition
Corp (the “Company”), we submit this letter setting forth the responses of the Company to the comments provided
by the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”)
in its comment letter dated May 26, 2023 (the “Comment Letter”) with respect to the Registration Statement
on Form S-4 filed with the Commission by the Company on April 7, 2023 (the “Registration Statement”)
and Amendment No. 1 thereto, filed with the Commission on May 12, 2023. Concurrently with the filing of this letter, the Company is filing
Amendment No. 2 (“Amendment No. 2”) to the Registration Statement through EDGAR.
For your convenience, we have set forth each comment
of the Staff from the Comment Letter in bold and italics below and provided our response below each comment. All references in this letter
to page numbers and captions correspond to the page numbers and captions in Amendment No. 2. Unless otherwise indicated,
capitalized terms used herein have the meanings assigned to them in Amendment No. 2.
Growth for Good Acquisition Corp
June 20, 2023
Page 2
Amendment No. 1 to Registration Statement on Form S-4
Cover Page
1. Please revise the cover page to clarify if the sponsor holds 80,000
or 800,000 Class A ordinary shares underlying the private placement units.
Response:
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on cover page of Amendment No.
2 to clarify that the sponsor holds 800,000 Class A ordinary shares underlying the private placement units.
Opinion of Marshall & Stevens, page 112
2. We note your response to comment 14 and
reissue. Please revise to disclose the specific data underlying each analysis referenced
in the disclosure.
Response: The
Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pages 117, 118, 122 and 123 of
Amendment No. 2 to provide the specific data underlying each analysis conducted by Marshall & Stevens.
Projected Financial Information, page 120
3. We note your response to comment 19 and
reissue in part. Please expand your discussion of the material assumptions underlying your
EBITDA projections, quantifying where applicable. Also explain in more detail how you arrived
at the revenue projections for 2024 and why the growth you project is reasonable. Describe
the "scaling of existing product lines" and "projects and products currently
in the pipeline" and how they relate to the projected revenue growth.
Response: The
Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pages 126 and 165 of Amendment
No. 2 accordingly.
Interests of G4G's Directors and Executive Officers in the Business
Combination, page 161
4. We note your response to comment 21 and reissue. Please quantify
the aggregate dollar amount and describe the nature of what the sponsor and its affiliates
have at risk that depends on completion of a business combination. Include the current value
of securities held, loans extended, fees due, and out-of-pocket expenses for which the sponsor
and its affiliates are awaiting reimbursement.
Response: The
Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pages 32, 33, 85, 166 and 167 of
Amendment No. 2. There are no material additional securities held, loans extended, fees due, and out-of-pocket expenses for which
Sponsor and its affiliates are awaiting reimbursement, except as otherwise disclosed in Amendment No. 2.
Growth
for Good Acquisition Corp
June 20, 2023
Page 3
Information about ZeroNox, page 236
5. We note your response to comment 34 and reissue. Please revise to
identify the large Japanese OEM of agricultural machines and utility vehicles.
Response:
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pages 255 and 256 of Amendment
No. 2. The Company has also re-filed Exhibits 10.12 and 10.12.1 to the Amendment No.1 and identified by name who the large Japanese OEM
is in the re-filed exhibits.
Annex I, page I-1
6. We note your response to comment 40 and reissue in part. Please revise
to provide the legal basis for the company's and the advisor's belief that security holders
cannot rely on the opinion to bring state law actions, including a description of any state
law authority on such a defense. If no such authority exists, please disclose that the issue
will be resolved by a court, resolution of the issue will have no effect on rights and responsibilities
of the board under state law, and the availability of this defense has no effect on the rights
and responsibilities of either the advisor or the board under the federal securities laws.
Response: The
Company respectfully acknowledges the Staff’s comment and has revised the disclosure on page 116 of Amendment No. 2 to
provide that whether the issue stated above would be enforced in favor of Marshall & Stevens and
against any securities holders or other persons would need to be resolved by a court of competent jurisdiction, and resolution of
such issue would have no effect on the rights and responsibilities of G4G’s Board under state law, and the availability of the
defense noted above would have no effect on the rights and responsibilities of either Marshall & Stevens or the G4G’s
Board under the federal securities laws.
General
7. Tell us whether Barclays or Credit Suisse were involved in the preparation
of any disclosure that is included in the registration statement, including any analysis
underlying disclosure in the registration statement. If so, clarify their involvement, whether
they have retracted any work product associated with the transaction, and the risk of such
withdrawal and reliance on their expertise. Further, please clarify that each of Barclays
and Credit Suisse claims no role in the SPAC’s business combination transaction and
has affirmatively disclaimed any responsibility for any of the disclosure in this registration
statement.
Response: The
Company respectfully acknowledges the Staff’s comment and advises the Staff that Barclays and Credit Suisse were not involved
in the preparation of any disclosure that is included in the Registration Statement or any amendment thereto, including any analysis
underlying disclosure in the Registration Statement or any amendment thereto. Each of Barclays and Credit Suisse claims no role in
the proposed Business Combination and has affirmatively disclaimed any responsibility for any of the disclosure in the Registration
Statement or any amendment thereto. In response to the Staff’s comment, the Company has revised the disclosure on pages 113,
225, 240 and 241 of Amendment No. 2.
Growth
for Good Acquisition Corp
June 20, 2023
Page 4
8. Please disclose whether Barclays or Credit Suisse assisted in the
preparation or review of any materials reviewed by the G4G's board of directors or management
as part of their services and whether Barclays and Credit Suisse have each withdrawn its
association with those materials and notified G4G of such disassociation. For context, include
that there are similar circumstances in which a financial institution is named and that Barclays'
or Credit Suisse's resignation indicates it is not willing to have the liability associated
with such work in this transaction.
Response:
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on page 241 of Amendment No. 2.
9. Please provide us with any correspondence between Barclays or Credit
Suisse and G4G/ZeroNox relating to Barclays' and Credit Suisse's resignations.
Response:
The Company respectfully acknowledges the Staff’s comment. In response to the Staff’s request to provide the above
correspondence, the Company is supplementally providing the deferred underwriting fee waiver letters received from each of Barclays and
Credit Suisse under separate cover in reliance on Rule 83 and Rule 418.
10. Please provide us with the engagement letter between G4G/ZeroNox
and Barclays and Credit Suisse. Please disclose any ongoing obligations pursuant to the engagement
letter that will survive the termination of the engagement, such as indemnification provisions,
rights of first refusal, and lockups, and discuss the impacts of those obligations on the
company in the registration statement.
Response:
The Company respectfully acknowledges the Staff’s comment and advises the Staff that there is no such engagement letter since
Barclays and Credit Suisse were not engaged in connection with the proposed Business Combination.
11. Please provide us with a letter from each of Barclays and Credit
Suisse stating whether it agrees with the statements made in your prospectus related to their
resignation and, if not, stating the respects in which they do not agree. Please revise your
disclosure accordingly to reflect that you have discussed the disclosure with each of Barclays
and Credit Suisse and it either agrees or does not agree with the conclusions and the risks
associated with such outcome. If Barclays and Credit Suisse do not respond, please revise
your disclosure to indicate you have asked and not received a response and disclose the risks
to investors. Additionally, please indicate that Barclays and Credit Suisse withdrew from
their roles and forfeited its fees, if applicable, and that the firm refused to discuss the
reasons for its resignation and forfeiture of fees, if applicable, with management. Clarify
whether each of Barclays and Credit Suisse performed substantially all the work to earn its
fees.
Response:
The Company respectfully acknowledges the Staff’s comment and advises the Staff that representatives of the Company provided
the disclosure in the Registration Statement (including amendments thereto) related to the waiver of the deferred underwriting fees to
each of Barclays and Credit Suisse and requested each to confirm it agrees with such disclosure and, if not, to state the respects in
which it does not agree. Following delivery of such disclosure to Barclays and Credit Suisse, they have stated that they do not intend
to review such disclosure. In response to the Staff's comment, the Company has revised the disclosure on pages 113 and 241 of Amendment
No. 2.
Growth for Good Acquisition Corp
June 20, 2023
Page 5
12. Please revise your disclosure to highlight for investors that Barclays'
and Credit Suisse's withdrawal indicates that it does not want to be associated with the
disclosure or underlying business analysis related to the transaction. In addition, revise
your disclosure to caution investors that they should not place any reliance on the fact
that each of Barclays and Credit Suisse has been previously involved with the transaction.
Response:
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on page 241 of Amendment No. 2.
13. Please discuss the potential impact on the transaction related to
the resignation of Barclays and Credit Suisse. We note that Barclays and Credit Suisse were
underwriters in the IPO of the SPAC. If Barclays or Credit Suisse would have played a role
in the closing, please revise to identify the party who will be filling Barclays' or Credit
Suisse's role.
Response:
The Company respectfully acknowledges the Staff’s comment advises the Staff that Barclays and Credit Suisse did not participate
in the proposed Business Combination, and therefore the waiver by each of Barclays and Credit Suisse of its deferred underwriting fee
does not impact the proposed Business Combination.
14. We understand that Barclays and Credit Suisse, underwriters in your
SPAC IPO, intend to waive the deferred underwriting commissions that would otherwise be due
to it upon the closing of the business combination. Please disclose how this waiver was obtained,
why the waiver was agreed to, and clarify the SPAC’s current relationship with Barclays
and Credit Suisse.
Response:
The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on pages 240 and 241 of Amendment
No. 2.
Growth for Good Acquisition Corp
June 20, 2023
Page 6
15. Please describe what relationship existed between Barclays and Credit
Suisse and G4G after the close of the IPO, including any financial or merger-related advisory
services conducted by Barclays or Credit Suisse. For example, clarify whether Barclays or
Credit Suisse had any role in the identification or evaluation of business combination targets.
Response:
The Company respectfully ackno